• 1258 Citations
  • 19 h-Index
20042019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Gianluca Spitaleri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Mutation Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Observational Studies Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

  • 1258 Citations
  • 19 h-Index
  • 76 Article
  • 1 Comment/debate
  • 1 Review article
4 Citations (Scopus)

Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations

Passaro, A., Prelaj, A., Bonanno, L., Tiseo, M., Tuzi, A., Proto, C., Chiari, R., Rocco, D., Genova, C., Sini, C., Cortinovis, D., Pilotto, S., Landi, L., Bennati, C., Camerini, A., Toschi, L., Putzu, C., Cerea, G., Spitaleri, G., Cappuzzo, F. & 1 others, de Marinis, F., Mar 1 2019, In : Clinical Lung Cancer. 20, 2, p. e186-e194

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Mutation
Exons
Point Mutation
3 Citations (Scopus)

5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer

Toffalorio, F., Santarpia, M., Radice, D., Jaramillo, C. A., Spitaleri, G., Manzotti, M., Catania, C., Jordheim, L. P., Pelosi, G., Peters, G. J., Tibaldi, C., Funel, N., Spaggiari, L., de Braud, F., De Pas, T. & Giovannetti, E., Jan 1 2018, In : Oncotarget. 9, 23, p. 16437-16450 14 p.

Research output: Contribution to journalArticle

gemcitabine
5'-Nucleotidase
Combination Drug Therapy
Platinum
Non-Small Cell Lung Carcinoma

5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer

Toffalorio, F., Santarpia, M., Radice, D., Jaramillo, C. A., Spitaleri, G., Manzotti, M., Catania, C., Jordheim, L. P., Pelosi, G., Peters, G. J., Tibaldi, C., Funel, N., Spaggiari, L., de Braud, F., De Pas, T. & Giovannetti, E., Mar 27 2018, In : Oncotarget. 9, 23, p. 16437-16450 14 p.

Research output: Contribution to journalArticle

gemcitabine
5'-Nucleotidase
Combination Drug Therapy
Platinum
Non-Small Cell Lung Carcinoma

Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations

Passaro, A., Prelaj, A., Bonanno, L., Tiseo, M., Tuzi, A., Proto, C., Chiari, R., Rocco, D., Genova, C., Sini, C., Cortinovis, D., Pilotto, S., Landi, L., Bennati, C., Camerini, A., Toschi, L., Putzu, C., Cerea, G., Spitaleri, G., Cappuzzo, F. & 1 others, de Marinis, F., Nov 20 2018, In : Clinical Lung Cancer. 9 p.

Research output: Contribution to journalArticle

Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Mutation
Exons
3 Citations (Scopus)

Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer

de Jong, E. E. C., van Elmpt, W., Rizzo, S., Colarieti, A., Spitaleri, G., Leijenaar, R. T. H., Jochems, A., Hendriks, L. E. L., Troost, E. G. C., Reymen, B., Dingemans, A. M. C. & Lambin, P., Oct 1 2018, In : Lung Cancer. 124, p. 6-11 6 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Tomography
Adenocarcinoma
Mutation
Survival